Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 304-313, July 2007

Novel and Traditional Cardiovascular Risk Factors for Peripheral Arterial Disease in Incident-Dialysis Patients

  • Bernard G. Jaar

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • Nephrology Center of Maryland, Baltimore, MD
    • Corresponding Author InformationAddress correspondence to Bernard G. Jaar, MD, MPH, Johns Hopkins Medical Institutions, Division of Nephrology, 2024 E. Monument Street, Suite 2-500, Baltimore, MD 21205.
  • ,
  • Laura C. Plantinga

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
  • ,
  • Brad C. Astor

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • ,
  • Nancy E. Fink

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • ,
  • Craig Longenecker

      Affiliations

    • Department of Community Medicine, Kuwait University, Safat, Kuwait
  • ,
  • Russell P. Tracy

      Affiliations

    • Laboratory for Clinical Biochemistry Research, Department of Pathology, University of Vermont, Colchester, VT
    • Dr Tracy is supported in part by HL 46696 and HL 58329.
  • ,
  • Santica M. Marcovina

      Affiliations

    • Northwest Lipid Research Laboratories, University of Washington, Seattle, WA
  • ,
  • Neil R. Powe

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • Dr. Powe is supported in part by K24-DK-02643 (NIDDK).
  • ,
  • Josef Coresh

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
    • Dr. Coresh is supported in part as an American Heart Association established investigator (01-4019-7N).

Peripheral arterial disease (PAD), which threatens limb viability and patient survival, is increasing in frequency in the dialysis population, but associated risk factors remain poorly defined. We conducted a cross-sectional analysis of the association of novel and traditional cardiovascular risk factors with PAD in incident-dialysis patients enrolled in the CHOICE study by application of multivariate logistic-regression models with adjustment for confounders. Risk factors were determined by interview, record review, and laboratory analysis of frozen specimens. Among 922 patients, 25% had a diagnosis of PAD. After adjustment, higher prevalence of PAD was associated with increasing age (odds ratio [OR], 95% CI = 1.28 [range: 1.12 to 1.48] per 10-year increase in age); presence of diabetes mellitus (OR, 95% CI = 2.76 [range: 1.72 to 4.42]); higher Index of Co-Existent Disease (ICED), ICED 2 and ICED 3 versus ICED 0-1, (OR, 95% CI = 2.04; [range: 1.24 to 3.35] and OR, 95% CI = 2.81 [range: 1.83 to 4.30], respectively). After adjustment, we found no statistically significant association between CRP and prevalence of PAD. The prevalence of PAD diagnosis was 34% higher per quartile increase in Lp(a) (OR, 95% CI = 1.34 [range: 1.13 to 1.59]). Similarly, the prevalence of PAD diagnosis was 19% higher per quartile increase in total homocysteine (OR, 95% CI = 1.19 [range: 1.05 to 1.35]). The prevalence of PAD is high in incident-dialysis patients and is associated with several novel and traditional cardiovascular risk factors. This study identifies several novel risk factors (eg, Lp(a) and total homocysteine) and underscores the need for further research to reduce the burden of PAD in this high-risk group of patients.

Index Words: Peripheral arterial disease, Dialysis, Homocysteine, Lipoprotein (a), C-reactive protein, Fibrinogen, End-stage renal disease, Risk factors, Prevalence

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 CHOICE is supported by RO1-HL-62985 (National Heart, Lung, and Blood Institute [NHLBI]) and RO1-DK-59616 (National Institute of Diabetes & Digestive & Kidney Diseases [NIDDK]).

PII: S1548-5595(07)00059-6

doi:10.1053/j.ackd.2007.04.005

Advances in Chronic Kidney Disease
Volume 14, Issue 3 , Pages 304-313, July 2007